Qube Research & Technologies (QRT)
EXEL icon

Qube Research & Technologies (QRT)’s Exelixis EXEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,400
Closed -$61.4K – 3686
2025
Q4 		$61.4K Hold
1,400
– – ﹤0.01% 3263
2025
Q3 		$57.8K Buy
+1,400
New +$56.3K ﹤0.01% 3161

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EXEL Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Exelixis (EXEL) stake by 100% in Q1 2026, selling an estimated $57.5M and leaving 6,623 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Qube Research & Technologies (QRT) first reported a position in EXEL in Q3 2018 and has held it in 23 quarters since. The position peaked at $134M in Q2 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Qube Research & Technologies (QRT) held 6,623 shares of Exelixis worth $284K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 1,337,603 Exelixis shares in Q1 2026, an estimated $57.5M.
  • Exelixis made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2879 holding.
  • Qube Research & Technologies (QRT) first reported a position in Exelixis in Q3 2018 and has held it in 23 quarters since.
  • Qube Research & Technologies (QRT)'s Exelixis position peaked at $134M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.